Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0000950170-24-022047
Filing Date
2024-02-28
Accepted
2024-02-28 16:04:46
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 pro_supp_feb_2024.htm 424B5 285877
2 GRAPHIC img108171751_0.jpg GRAPHIC 8009
3 GRAPHIC img108171751_1.jpg GRAPHIC 4115
4 GRAPHIC img108171751_2.jpg GRAPHIC 8009
5 GRAPHIC img108171751_3.jpg GRAPHIC 8009
  Complete submission text file 0000950170-24-022047.txt   326358
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 424B5 | Act: 33 | File No.: 333-277201 | Film No.: 24695176
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)